Your shopping cart is currently empty

A2AAR antagonist 3 is a potent and selective A2A adenosine receptor (A2AAR) antagonist with an IC50 value of 1.57 nM. It exhibits a high binding affinity specifically for A2AAR. In vitro studies demonstrate its good stability in rat liver microsomes, and it possesses acceptable pharmacokinetic properties in vivo. A2AAR antagonist 3 is applicable for cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | A2AAR antagonist 3 is a potent and selective A2A adenosine receptor (A2AAR) antagonist with an IC50 value of 1.57 nM. It exhibits a high binding affinity specifically for A2AAR. In vitro studies demonstrate its good stability in rat liver microsomes, and it possesses acceptable pharmacokinetic properties in vivo. A2AAR antagonist 3 is applicable for cancer research. |
| In vitro | A2AAR antagonist 3 (Compound 12a) at a concentration of 1 μM over 48 hours can restore IL-2 secretion in human peripheral blood mononuclear cells inhibited by NECA (1 μM, pretreated for 30 minutes). Furthermore, A2AAR antagonist 3, within a range of 3.125-100 μM over 24 hours, shows no significant toxicity to L929, H9C2, and HTX2426 cells. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.